U.S. Electrical Stock News

NYSE:CAH
NYSE:CAHHealthcare

Cardinal Health (CAH) Valuation Check As Income Drop And Goodwill Impairment Pressure The Story

Why Cardinal Health (CAH) is back in focus after its latest quarter Cardinal Health (CAH) has moved back onto investors’ radar after its third quarter results showed a year-over-year decline in net income and a sizeable goodwill impairment tied to its Navista and ION unit. These profit and impairment headlines came alongside large pharmaceutical distribution sales, ongoing share repurchases, and an updated dividend. Together, they provide several angles to reassess how the stock fits into a...
NYSE:LNC
NYSE:LNCInsurance

Is Lincoln National’s (LNC) Shift Toward Less Market‑Sensitive Products Redefining Its Core Earnings Power?

In early May 2026, Lincoln National reported first‑quarter revenue of US$5,306 million and a net loss of US$172 million, while also announcing expanded managed account offerings with Stadion and Morningstar Retirement and deeper API integration with Centro Benefits Research to streamline broker workflows. Despite the GAAP loss, Lincoln National delivered its seventh consecutive quarter of adjusted operating income growth and continued shifting toward less market‑sensitive products, while...
NasdaqGS:PEP
NasdaqGS:PEPBeverage

PepsiCo Buys Poppi For US$1.95b To Expand Health Focus

PepsiCo (NasdaqGS:PEP) is acquiring prebiotic soda brand Poppi in a deal valued at $1.95b. The transaction adds a fast growing functional soda label focused on gut health to PepsiCo’s beverage lineup. The move reflects continued investment in health focused soft drinks alongside the company’s traditional soda and snack offerings. PepsiCo, which last closed at $149.27, has seen the stock rise 4.9% year to date and 20.9% over the past year, while returns over 3 years show a decline of 14.0%...
NYSE:FMC
NYSE:FMCChemicals

Does FMC’s (FMC) Steady 2026 Outlook Signal Pricing Power Or Reliance On New Products?

FMC Corporation recently maintained its 2026 earnings guidance, projecting second-quarter revenue of US$850 million to US$900 million and full-year sales of US$3.60 billion to US$3.80 billion, while confirming a sales decline at the midpoint due to lower prices and the removal of India revenue partly offset by volume growth from new products. Earlier today, FMC’s CEO Pierre Brondeau and CFO Andrew Sandifer spoke at the BMO Global Farm to Market Chemicals Conference in New York, giving...
NasdaqGS:VRSK
NasdaqGS:VRSKProfessional Services

Is It Time To Reassess Verisk Analytics (VRSK) After Its Steep Share Price Slide?

If you are wondering whether Verisk Analytics at around US$161 a share still represents good value, the current market price alone does not tell the full story. The stock is down 5.5% over the past week, 3.8% over the past month and 26.9% year to date. It has declined 46.0% over the last year and 24.9% over three years, which has shifted how many investors are thinking about both risk and potential upside. Recent headlines have focused on Verisk Analytics as a data and analytics provider in...
NasdaqGS:CVLT
NasdaqGS:CVLTSoftware

Commvault Sale Talks Put Mixed Shareholder Returns In Fresh Focus

Commvault Systems (NasdaqGS:CVLT) is reportedly working with Goldman Sachs to review takeover interest. Potential bidders are said to include both private equity firms and industry buyers. The process is at an exploratory stage and could influence the future ownership and direction of the company. For shareholders, this comes at a time when Commvault Systems is trading at around $99.81, with the stock down 19.6% year to date and down 44.5% over the past year, while still showing a gain of...
NasdaqGM:HROW
NasdaqGM:HROWPharmaceuticals

Why Harrow (HROW) Is Down 25.9% After Q1 Miss And Reaffirmed 2026 Guidance – And What's Next

Harrow, Inc. reported past first-quarter 2026 results with revenue of US$44.2 million versus US$47.83 million a year earlier and a wider net loss of US$27.6 million, missing analyst expectations on both revenue and earnings. Management attributed much of the revenue pressure to an US$8 million non-recurring VEVYE gross-to-net adjustment while highlighting record VEVYE prescriptions and reaffirming full-year 2026 revenue guidance of US$350 million to US$365 million. We’ll now examine how...
NYSE:PR
NYSE:PROil and Gas

How Weak Q1 Earnings but Strong Free Cash Flow and Dividend At Permian Resources (PR) Has Changed Its Investment Story

In early May 2026, Permian Resources Corporation reported first-quarter 2026 results showing net income of US$43.62 million versus US$329.30 million a year earlier, alongside a quarterly base dividend declaration of US$0.16 per Class A share payable on June 30, 2026. While earnings and earnings per share fell sharply and revenue missed analyst expectations, management highlighted record-low well costs, more than US$500 million in free cash flow, and ongoing plans to return capital through...
NYSE:ONON
NYSE:ONONLuxury

A Look At On Holding (ONON) Valuation After Record Q1 Results And Higher 2026 Margin Guidance

On Holding (NYSE:ONON) has become a focus for investors after reporting a record first quarter, raising its 2026 profit margin guidance, and installing returning co-founders as co-CEOs during a broader international expansion. See our latest analysis for On Holding. Despite the strong first quarter and raised profitability guidance, the stock has been weak this year, with a year to date share price return of down 24.62% and a 1 year total shareholder return of down 38.55%, while the 3 year...
NYSE:CLX
NYSE:CLXHousehold Products

Clorox (CLX) Valuation Check After Recent Share Price Rebound And Ongoing ERP Transition Narrative

Why Clorox Stock Is on Investors’ Radar Today Clorox (CLX) is drawing fresh attention after recent share price moves. The stock closed at US$92.00 as investors weigh its household, health and wellness, lifestyle, and international product exposure. See our latest analysis for Clorox. The recent 1-day share price return of 3.24% and 7-day share price return of 2.21% come after a tougher patch, with the 30-day share price return down 11.02% and the 90-day share price return down 26.19%. The...
NasdaqCM:LXRX
NasdaqCM:LXRXPharmaceuticals

Lexicon Pharmaceuticals (LXRX) Is Up 52.5% After Q1 Loss Narrows And Revenue Jumps - Has The Bull Case Changed?

Lexicon Pharmaceuticals, Inc. reported first-quarter 2026 results on May 7, with revenue rising to US$21.1 million from US$1.26 million a year earlier and net loss narrowing to US$1.04 million from US$25.3 million. Alongside this sharp improvement in quarterly financials, Lexicon recently secured up to US$100 million in non-dilutive debt capacity, extending its funding runway for upcoming regulatory and commercial milestones. With revenue sharply higher and net loss greatly reduced, we’ll...
NYSE:AMN
NYSE:AMNHealthcare

A Look At AMN Healthcare Services (AMN) Valuation After Its Sharp Recent Share Price Surge

Recent performance and business snapshot AMN Healthcare Services (AMN) has drawn attention after a sharp move in the stock, with recent returns of 4.8% over the past day, roughly 47% over the past week, and about 66% over the past month. Over the past 3 months the stock is up about 90%, while the year to date gain is about 104% and the 1 year total return is about 42%. These moves come as the company reports annual revenue of US$3,419.3m and a net loss of US$32.4m, alongside annual revenue...
NYSE:IOT
NYSE:IOTSoftware

Samsara’s New AI Public Sector Tools And What They Mean For Investors

Samsara (NYSE:IOT) has launched multiple new AI-powered solutions tailored for the public sector. The new tools include Ground Intelligence for road condition monitoring, Waste Intelligence for service verification, and Ridership Management for school transportation safety. These products focus on infrastructure, safety, and operational efficiency for government agencies and community organizations. Samsara enters this announcement with its stock at $27.52 and a mixed return profile, with...
NYSE:ICL
NYSE:ICLChemicals

Why ICL Group (ICL) Is Up 21.4% After Raising 2026 EBITDA Guidance and Q1 Dividend Approval

ICL Group Ltd has reported its first-quarter 2026 results, posting sales of US$2,023 million and net income of US$126 million, with earnings per share rising to US$0.10 from US$0.07 a year earlier and a cash dividend of US$0.05350 per share approved for June 17, 2026. Beyond the headline beat and guidance upgrade, ICL’s decision to raise full-year adjusted EBITDA expectations while maintaining potash volume targets highlights an emphasis on margin quality, supported by higher-value specialty...
NasdaqCM:NAGE
NasdaqCM:NAGEPersonal Products

Is Niagen Bioscience’s (NAGE) Telehealth Niagen Plus Launch a Turning Point in Its Direct-Access Strategy?

In early May 2026, Niagen Bioscience, Inc. launched its Niagen Plus clinician-directed telehealth platform in the U.S., offering prescription-only, pharmaceutical-grade Niagen via a first-of-its-kind at-home subcutaneous injection kit dispensed through licensed 503A pharmacies. This move marks Niagen Bioscience's first direct-to-client access model, potentially widening its addressable market by combining telehealth, at-home delivery, and injectable NAD+ support under medical...
NasdaqGS:CRWV
NasdaqGS:CRWVIT

Assessing CoreWeave (CRWV) Valuation After Volatile Reaction To Q1 Results And Higher AI Infrastructure Spending

CoreWeave (CRWV) is back in focus after its first quarter report, which combined rapid sales growth with a wider net loss and stirred debate about how investors should weigh near-term losses against long-term AI infrastructure demand. See our latest analysis for CoreWeave. Recent news, including CoreWeave’s widened quarterly loss, softer near term outlook, major insider sales and fresh AI infrastructure deals, has fueled sharp swings. The 7 day share price return is down 19.33%, while the 1...
NYSE:VIRT
NYSE:VIRTCapital Markets

Virtu Financial (VIRT) Is Up 6.8% After Record Q1 Earnings And New Zerohash Partnership

In early May 2026, Zerohash announced that Virtu Financial had joined its liquidity ecosystem as a market-making partner, adding Virtu’s two-sided liquidity to Zerohash’s central limit order book and RFQ systems for broker-dealers, banks, fintechs, and payment providers. Around the same time, Virtu reported record-breaking first-quarter 2026 earnings that exceeded analyst expectations, highlighting how its market-making expertise is increasingly intersecting with rapidly growing digital...
NYSE:BBT
NYSE:BBTBanks

Beacon Financial Earnings Jump As Merger Integration Reshapes Funding And Costs

Beacon Financial (NYSE:BBT) reported first quarter 2026 earnings that were more than double the prior year. The company highlighted higher net and non interest income tied to its 2025 merger. Management also outlined progress on post merger integration and related expenses. For investors watching NYSE:BBT, these results come at a time when the stock is trading at $28.38 and is up 7.5% year to date. Over the past month the share price is down 10.4%, which puts extra focus on how the merger...
NYSE:OVV
NYSE:OVVOil and Gas

Should Ovintiv’s (OVV) Cash Generation Amid Q1 Losses Require Action From Investors?

Ovintiv Inc. has already reported first-quarter 2026 results, with revenue rising to US$2,532 million while a US$630 million net loss reflected large non-cash impairments alongside active portfolio reshaping and a US$0.30 per-share dividend declaration. Amid higher production volumes, reaffirmed 2026 guidance, and resumed share buybacks, Ovintiv paired a wider accounting loss with strong cash generation and an ongoing commitment to returning free cash flow to shareholders. We will now...
NasdaqGS:ATEC
NasdaqGS:ATECMedical Equipment

Insider Buying And New Credit Facility Reshape Alphatec Holdings Risk Profile

In May 2026, Alphatec Holdings director Keith Valentine made substantial insider purchases of NasdaqGS:ATEC shares. At the same time, Alphatec refinanced its debt with a new syndicated bank credit facility. The facility adjusts the company’s interest costs and extends debt maturities, while simplifying its capital structure. Alphatec Holdings, listed on NasdaqGS:ATEC, focuses on spine surgery solutions, a segment that often attracts attention as populations age and demand for orthopedic and...
NYSE:NVST
NYSE:NVSTMedical Equipment

A Look At Envista Holdings (NVST) Valuation After Recent Share Price Weakness

Envista Holdings stock performance snapshot Envista Holdings (NVST) has seen its stock decline around 1% over the past day and about 12% over the past week, with the move extending to roughly 11% over the past month. Over the past 3 months, the stock is down about 17%. The year-to-date return remains positive at roughly 10%, and the 1-year total return is about 33%. See our latest analysis for Envista Holdings. The recent slide, including a 1-week share price return of down 11.64% and a...
NasdaqGS:TER
NasdaqGS:TERSemiconductor

A Look At Teradyne (TER) Valuation After Powerful One Year And Five Year Shareholder Returns

Teradyne (TER) continues to draw attention after recent trading, with the stock closing at $363.38 and posting a year to date total return of 75.07%, alongside a 1 year total return above 300%. See our latest analysis for Teradyne. The latest share price of $363.38 comes after a 1 day share price return of 1.38% and a 90 day share price return of 15.48%. The 1 year total shareholder return of 339.48% and 5 year total shareholder return of 192.75% indicate strong momentum over both shorter and...
NasdaqGS:SFM
NasdaqGS:SFMConsumer Retailing

Is Sprouts (SFM) Becoming a Preferred Gateway for Wellness Brands and Investors Alike?

In early May 2026, BODi announced that its Shakeology line would roll out in convenient seven-serving bags priced at US$34.99 across more than 80 Sprouts Farmers Market stores nationwide, while Sprouts also presented at the 21st Annual Global Farm to Market Conference. These developments, alongside Sprouts’ recent earnings beat and continued focus on health and wellness, underline how outside brands and institutional investors are increasingly viewing Sprouts as an important gateway to...
NYSE:Q
NYSE:QSemiconductor

Qnity Electronics (Q) Is Up 8.4% After Raising 2026 AI‑Driven Guidance – Has The Bull Case Changed?

In May 2026, Qnity Electronics reported first‑quarter 2026 results showing net sales rising to US$1.315 billion while GAAP net income and earnings per share fell year over year, but adjusted earnings and margins improved. The company also raised its full‑year 2026 guidance for sales and adjusted earnings, highlighting strong demand from AI and high‑performance computing customers, reinforced by new collaborations with Nvidia and participation in Apple’s American Manufacturing program. Next,...